92 related articles for article (PubMed ID: 25736765)
1. Methods for assessing the in vitro transforming activity of NF-κB transcription factor c-Rel and related proteins.
Gilmore TD; Gélinas C
Methods Mol Biol; 2015; 1280():427-46. PubMed ID: 25736765
[TBL] [Abstract][Full Text] [Related]
2. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
[TBL] [Abstract][Full Text] [Related]
3. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
Gilmore TD; Cormier C; Jean-Jacques J; Gapuzan ME
Oncogene; 2001 Oct; 20(48):7098-103. PubMed ID: 11704834
[TBL] [Abstract][Full Text] [Related]
4. Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes.
Fan Y; Rayet B; Gélinas C
Oncogene; 2004 Feb; 23(5):1030-42. PubMed ID: 14647412
[TBL] [Abstract][Full Text] [Related]
5. Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.
Starczynowski DT; Reynolds JG; Gilmore TD
Oncogene; 2003 Oct; 22(44):6928-36. PubMed ID: 14534540
[TBL] [Abstract][Full Text] [Related]
6. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.
Starczynowski DT; Reynolds JG; Gilmore TD
Oncogene; 2005 Nov; 24(49):7355-68. PubMed ID: 16027730
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile.
Chin M; Herscovitch M; Zhang N; Waxman DJ; Gilmore TD
Oncogene; 2009 May; 28(20):2100-11. PubMed ID: 19377508
[TBL] [Abstract][Full Text] [Related]
8. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
[TBL] [Abstract][Full Text] [Related]
9. An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation.
Fan Y; Gélinas C
Oncogene; 2007 Jun; 26(27):4038-43. PubMed ID: 17173064
[TBL] [Abstract][Full Text] [Related]
10. 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB.
Shin SR; Sánchez-Velar N; Sherr DH; Sonenshein GE
Cancer Res; 2006 Mar; 66(5):2570-5. PubMed ID: 16510574
[TBL] [Abstract][Full Text] [Related]
11. Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8.
Garbati MR; Alço G; Gilmore TD
Cancer Lett; 2010 May; 291(2):237-45. PubMed ID: 19948376
[TBL] [Abstract][Full Text] [Related]
12. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
13. Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding site.
Capobianco AJ; Gilmore TD
Oncogene; 1991 Dec; 6(12):2203-10. PubMed ID: 1766669
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins.
White DW; Gilmore TD
Oncogene; 1996 Sep; 13(5):891-9. PubMed ID: 8806678
[TBL] [Abstract][Full Text] [Related]
15. Envelope-dependent transactivation by the retroviral oncoprotein v-Rel is required for efficient malignant transformation of chicken spleen cells.
Epinat JC; Dvorin EL; Gilmore TD
Oncogene; 2000 Jun; 19(28):3131-7. PubMed ID: 10918567
[TBL] [Abstract][Full Text] [Related]
16. The v-Rel oncoprotein complexes with new Rel- and RelA-related proteins in transformed cells.
Xu X; Gélinas C
Virology; 1995 Mar; 207(2):362-8. PubMed ID: 7886940
[TBL] [Abstract][Full Text] [Related]
17. NF-kappa B p100 is one of the high-molecular-weight proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.
Sif S; Gilmore TD
J Virol; 1993 Dec; 67(12):7612-7. PubMed ID: 8230480
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a human REL-estrogen receptor fusion protein with a reverse conditional transforming activity in chicken spleen cells.
Kalaitzidis D; Ok J; Sulak L; Starczynowski DT; Gilmore TD
Oncogene; 2004 Sep; 23(45):7580-7. PubMed ID: 15326488
[TBL] [Abstract][Full Text] [Related]
19. cRel-TD kinase: a serine/threonine kinase binding in vivo and in vitro c-Rel and phosphorylating its transactivation domain.
Fognani C; Rondi R; Romano A; Blasi F
Oncogene; 2000 Apr; 19(18):2224-32. PubMed ID: 10822372
[TBL] [Abstract][Full Text] [Related]
20. Participation of the E3-ligase TRIM13 in NF-κB p65 activation and NFAT-dependent activation of c-Rel upon T-cell receptor engagement.
Hatchi EM; Poalas K; Cordeiro N; N'Debi M; Gavard J; Bidère N
Int J Biochem Cell Biol; 2014 Sep; 54():217-22. PubMed ID: 25088585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
